Results 211 to 220 of about 29,324 (231)
Some of the next articles are maybe not open access.
Atherosclerosis, 1994
Rationale and development of a new fenofibrate formulation is described. A lower dispersion of particles size and thereby a better absorption rate leads to a decrease of the daily dose and provides a better control of the amount absorbed. Improved reproducibility of the pharmacological and therapeutic effect is expected.
A, Munoz, J P, Guichard, P, Reginault
openaire +2 more sources
Rationale and development of a new fenofibrate formulation is described. A lower dispersion of particles size and thereby a better absorption rate leads to a decrease of the daily dose and provides a better control of the amount absorbed. Improved reproducibility of the pharmacological and therapeutic effect is expected.
A, Munoz, J P, Guichard, P, Reginault
openaire +2 more sources